Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients

Journal of Clinical Oncology

Volumn 16, Issue 11, 1998, Pages 3556-3562

  De Crevoisier, R ^a   Bourhis, J ^a   Domenge, C ^a   Wibault, P ^a   Koscielny, S ^a   Lusinchi, A ^a   Mamelle, G ^a   Janot, F ^a   Julieron, M ^a   Leridant, A M ^a   Marandas, P ^a   Armand, J P ^a   Schwaab, G ^a   Luboinski, B ^a   Eschwege, F ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA; MITOMYCIN;

ARTICLE; BONE NECROSIS; CANCER RECURRENCE; FIBROSIS; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; MORBIDITY; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; PALLIATIVE THERAPY; PRIORITY JOURNAL; REMISSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; WORLD HEALTH ORGANIZATION;

EID: 0031764049     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.11.3556     Document Type: Article

References (45)

1. Million R, Cassisi N, Clark J: Cancer of the head and neck, in De Vita VT, Hellman S, Rosenberg SA, (eds): Cancer: Principles and Practice of Oncology. Philadelphia, PA, Lippincott, 1989, pp 488-590
2. Hong W, Bromer R, Amato D, et al: Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality treatment. Cancer 45:1242-1245, 1985
3. Lippman S, Hong W: Second malignant tumors in head and neck squamous carcinoma: The overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 17:691-694, 1989
4. Ridge J: Squamous cancer of head and neck: Surgical treatment of local and regional recurrence. Semin Oncol 20:419-429, 1993
5. Williams R: Recurrent head and neck cancer: The results of treatment. Br J Surg 61:691-697, 1974
6. Hong W, Bromer R: Chemotherapy in head and neck cancer. Current concepts. N Engl J Med 308:75-79, 1983
7. Leone L, Albata M, Rege V: Treatment of carcinoma of the head and neck with intravenous methotrexate. Cancer 21:828-837, 1968
8. Woods R, Fox R, Tattersall M: Methotrexate treatment of squamous cell head and neck cancer: Dose response evaluation. Br Med J 282:600-602, 1981
9. Forastiere A: Chemotherapy of head and neck cancer. Ann Oncol S3:11-14, 1992
10. Jacobs C, Bertino J, Goffinet D, et al: 24 Hours infusion of cisplatinum in head and neck cancer. Cancer 42:2135-2140, 1978
11. Wittes R, Heller R, Randolph V, et al: Cis-dichlorodiammineplatinum II based chemotherapy in advanced head and neck cancer. Cancer Treat Rep 63:1533-1538, 1979
12. Eisenberger M, Hordeno J, Silva H, et al: Carboplatin, an active platinum analog for the treatment of squamous cell carcinoma of the head and neck. J Clin Oncol 4:1506-1509, 1986
13. Vokes E, Weichselbaum R, Lipman S, et al: Head and neck cancer. N Engl J Med : 184-194, 1993
14. Cortes E, Kalra J, Amin V: Chemotherapy for head and neck cancer relapsing after radiotherapy. Cancer 47:1966-1970, 1981
15. Livingstone R, Einhorn L, Burgess M: Sequential combination chemotherapy for advanced recurrent squamous carcinoma of the head and neck. Cancer Treat Rep 60:103-105, 1976
16. Forastiere A, Metch B, Schuller D: Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 10:1241-1251, 1992
17. Jacobs C, Lyman G, Velez-Garcia E: A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10:257-263, 1992
18. Deconti R, Schoenfeld D: A randomized prospective comparison of intermittent methotrexate, with leucovorin and a methotrexate combination in head and neck cancer. Cancer 48:1061-1072, 1981
19. Kaplan B, Schoenfeld D, Vogl S: Treatment of recurrent or metastatic squamous cancer of the head and neck with methotrexate, M plus Corynebacterium pavum, or M plus bleomycin plus diamminedi-chloroplatinum-A prospective randomized trial of the Eastern Cooperative Oncology Group. Proc Am Assoc Cancer Res 22:532, 1981 (abstr)
20. Williams S, Einhorn L, Velez-Garcia E: Chemotherapy of head and neck cancer: Comparison of cisplatin + vinblastine + bleomycin (PVB) versus methotrexate (MTX). Proc Am Soc Clin Oncol 1:202. 1982 (abstr)
21. Haraf D, Weichselbaum R, Vokes E: Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease. Ann Oncol 7:913-918, 1996
22. International Commission on Radiation Units and Measurements: ICRU report no. 50: Prescribing. Recording and Reporting Photon Beam Therapy. Bethesda, MD, ICRU, September 1, 1993
23. Cox D: Regression models and lifetables. J R Stat Soc B 34:187-220, 1972
24. Haraf D, Vokes E, Weichselbaum R, et al: Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor prognostic head and neck cancer. Laryngoscope 102:630-636, 1992
25. Gandia D, Wibault P, Guillot T, et al: Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer. Head Neck 15:8-15, 1993
26. Benchalal M, Bachaud JM, Francois P, et al: Hyperfractionation in the reirradiation of head and neck cancers. Result of a pilot study. Radiother Oncol 36:203-210, 1995
27. McNeese M, Fletcher G: Retreatment of recurrent nasopharyngeal carcinoma. Radiology 138:191-193, 1981
28. Wang C: Re-irradiation of recurrent nasopharyngeal carcinoma-Treatment technique and results. Int J Radiat Oncol Biol Phys 13:953-956, 1987
29. Wang C, McIntyre J: Re-irradiation of laryngeal carcinoma. Techniques and results. Int J Radiat Oncol Biol Phys 26:783-785, 1993
30. Langlois D, Eschwège F, Kramar A, et al: Reirradiation of head and neck cancers. Presentation of 35 cases treated at the Gustave Roussy Institute. Radiother Oncol 3:27-33, 1985
31. Tercilla O, Schmidt-Ullrich R, Wazer D: Reirradiation of head and neck neoplasms using twice-a-day scheduling. Strahlenther Onkol 169:285-290, 1993
32. Pomp J, Levendag P, van Putten W: Reirradiation of recurrent tumors in the head and neck. Am J Clin Oncol 11:543-549, 1988
33. Levendag P, Meeuwis C, Visser A: Reirradiation of recurrent head and neck cancers: External and/or interstitial radiation therapy. Radiother Oncol 23:6-15, 1992
34. Stevens JR, Britsch A, Moss W: High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 29:687-698, 1994
35. Yan J, Hu Y, Gu X: Radiation therapy of recurrent nasopharyngeal carcinoma. Report of 219 patients. Acta Radiol Oncol 22:23-28, 1983
36. Slolyszewski J, Korzeniowski S, Reinfuss M: The reirradiation of recurrences of head and neck cancer. Br J Radiol 53:462-465, 1980
37. Orecchia R, Airoldi M, Sola B, et al: Results of chemotherapy plus external reirradiation in the treatment of locally advanced recurrences of nasopharyngeal carcinoma. Eur J Cancer Oral Oncol 28B: 109-111, 1992
38. Weppelmann B, Wheeler R, Peters G, et al: Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation. Int J Radiat Oncol Biol Phys 22:1051-1056, 1992
39. Emami B, Bignardi M, Spector GJ, et al: Reirradiation of recurrent head and neck cancers. Laryngoscope 97:85-88, 1987
40. Lee A, Law S, Foo W, et al: Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: Survival after local recurrence. Int J Radiat Oncol Biol Phys 26:773-782, 1993
41. Pryzant M, Wendt C, Declos L, et al: Re-treatment of nasopharyngeal carcinoma in 53 patients. Int J Radiat Oncol Biol Phys 29:687-698, 1992
42. Haraf D, Vokes E, Panje W, et al: Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer. Am J Clin Oncol 14:419-426, 1991
43. Fu K, Newman H, Phillips T: Treatment of locally recurrent carcinoma of the nasopharynx. Radiology 117:425-431, 1975
44. Brockstein B, Haraf D, Stenson K, et al: Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck. J Clin Oncol 16:735-744, 1998
45. Wang C: To reirradiate or not to reirradiate? Int J Radiat Oncol Biol Phys 29:913, 1994